Status:
RECRUITING
Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients
Lead Sponsor:
Centre Jean Perrin
Conditions:
Triple Negative Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The PERCEPTION study aims to assess the correlation between blood cell counts (Leucocytes, Neutrophils, Lymphocytes, Platelets, NLR (Neutrophil-to-Lymphocyte Ratio) and PLR (Platelet-to-Lymphocyte Rat...
Detailed Description
Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer. Because of the limited therapeutical strategies, early TNBC relapses are quite common during the five years following...
Eligibility Criteria
Inclusion
- Female
- Age \> 18 years
- Diagnosed with primitive, non-metastatic, histologically proved, triple negative breast cancer
- Patient treated with chemotherapy, surgery and radiation therapy
- Patient able to understand the French language
- Patient affiliated to social security
- Obtaining signed written consent
Exclusion
- Male
- Unavailable tumoral samples before inclusion
- Unavailable blood test results at baseline, before inclusion
Key Trial Info
Start Date :
December 4 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2032
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04068623
Start Date
December 4 2019
End Date
October 1 2032
Last Update
February 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Jean PERRIN
Clermont-Ferrand, Please Select, France, 63000